Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat in Obese Patients With Hyperlipidemia
ChiCTR-IPR-17010887Phase 4Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of orlistat in obesity and hyperlipidemia (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoints: Body weight and Body mass index (BMI). Started Dec 2016; status: recruiting.
02
Drugs
orlistat
03
Conditions
obesityhyperlipidemia
Beyond the preview
Go deeper on ChiCTR-IPR-17010887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010887.